Plateaued on Mounjaro: why weight loss slows and what actually helps

Why your body hits the brakes — and why that is not a sign something has gone wrong

A plateau after several months on Mounjaro is almost always a sign that your physiology is working as expected, not that the medicine has stopped working. As body weight decreases, your basal metabolic rate falls alongside it, a smaller body simply burns fewer calories at rest. The gap between what you eat and what you burn, which drove early losses, narrows without any change in behaviour at all. This is adaptive thermogenesis, and it happens whether you are on tirzepatide, semaglutide, or any other weight-management approach.

There is also a hormonal layer. Fat loss triggers changes in appetite-regulating hormones like leptin and ghrelin that push back against continued weight reduction. Tirzepatide blunts those signals significantly (it acts on both the GIP and GLP-1 receptors, which is why it typically produces greater average weight loss than single-pathway medicines) but it does not remove the adaptation entirely. The NHS's overview of tirzepatide on the NHS medicines pages describes this dual mechanism, and it is worth reading if you want the mechanism explained in plain terms.

If you want to understand the specific reasons this happens, our page on why you may have plateaued on Mounjaro walks through the physiology in detail. That does not mean it is permanent. It means you have reached a decision point about what to do next.

The dose question: is there clinical room to progress?

A question our prescribers hear most weeks is: "I've been on the same dose for months and the scales haven't moved, should I go up?" The honest answer is: sometimes yes, sometimes no, and only a clinical review of your current dose, your response history and your tolerance can tell you which.

Tirzepatide is licensed at six strengths (2.5, 5, 7.5, 10, 12.5 and 15 mg) and the standard approach is to titrate upward in roughly four-week steps as tolerated. Many people plateau at mid-range doses while still below the maximum. If you are at, say, 5 or 7.5 mg and your weight has stalled for six to eight weeks, your prescriber may well consider whether a dose increase is appropriate given your side-effect profile and overall health picture. If you are already at 15 mg, that option is no longer on the table, and the conversation shifts.

What a prescriber will not do is increase a dose based on a plateau alone without reviewing your overall situation. Evidence of your current weight and any side effects you have experienced matters. For context on how the wider plateau question sits alongside Mounjaro's clinical profile, the Mounjaro overview on this site covers the evidence in more detail. If you are mid-titration and wondering how quickly results typically emerge, the page on how long Mounjaro takes to work gives a realistic timeline.

Lifestyle drift and what the evidence shows

Mounjaro reduces appetite powerfully in most people, and that suppression can make it easy to assume that food intake is well controlled. It often is, but appetite suppression is not the same as zero calorie drift. Over months, portion sizes can creep up, particularly for calorie-dense foods that are easy to eat even when not hungry (cheese, alcohol, ultra-processed snacks). Physical activity can also quietly decline as fatigue from reduced intake, or simply routine, takes hold.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20 to 21% at the 15 mg dose over 72 weeks, but all participants followed structured lifestyle guidance alongside the medicine. Real-world results without that structure tend to be lower and plateau sooner. A dietitian review or a structured look at protein intake, fibre and hydration often moves a stalled scale more than people expect.

Strength-based activity deserves a specific mention. During significant weight loss, lean muscle mass is at risk of reduction. Less muscle lowers resting metabolic rate further, deepening the plateau effect. Resistance training (even light bodyweight work at home) helps preserve muscle and supports ongoing loss. This is not about exercising the weight off; it is about protecting the metabolic engine that determines where your new equilibrium sits.

What to do now: the decision in practical terms

If you have plateaued on Mounjaro, there are a few distinct paths, and they are not mutually exclusive. First, check whether your dose has genuine headroom and discuss a possible increase with your prescriber at your next review. Second, look honestly at the lifestyle side (protein adequacy, calorie-dense food habits, activity level) because the medicine works best alongside real behavioural support, not instead of it. Third, consider whether the plateau has lasted long enough to warrant a formal clinical conversation rather than waiting it out.

The NICE appraisal of tirzepatide, TA1026, notes that continuing beyond six months at the highest tolerated dose is reviewed if less than 5% weight loss has occurred, a useful benchmark for thinking about when a plateau crosses into a signal that the current plan needs rethinking. That is a clinical judgement, not a self-assessment.

Some people find it useful to look at how the tirzepatide plateau pattern compares with other GLP-1 medicines; the broader tirzepatide plateau page covers those comparisons. For a deeper look at the specific reasons plateaus occur at different doses and timepoints, our guide to the Mounjaro plateau goes further into the physiology, and if you are already mid-treatment and finding progress has stalled, the page on plateauing on Mounjaro looks at what you can do to move things forward. And if you are considering what the next clinical step looks like for you, an overview of the weight-loss treatment options available privately in the UK is a reasonable starting point.

Plateaus are frustrating, especially after months of visible progress. They are also normal. The right response is a clinical conversation, not a change made alone. If you are thinking about what a review would involve, you can start a free consultation with a GPhC-registered prescriber at nume who will look at your situation the same day.